Homestead Advisers Corp Icu Medical Inc Transaction History

Homestead Advisers Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$151.88 - $189.51 $7.97 Million - $9.95 Million	-52,498 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$154.21 - $257.38 $1.7 Million - $2.83 Million	-11,000 Reduced 17.32%	52,498 $8.38 Million
Q2 2019 Aug 12, 2019	BUY	$212.8 - $251.91 $6.06 Million - $7.18 Million	28,498 Added 81.42%	63,498 $16 Million
Q1 2019 May 14, 2019	BUY	$221.09 - $253.28 $1.11 Million - $1.27 Million	5,000 Added 16.67%	35,000 $8.38 Million
Q4 2018 Feb 13, 2019	BUY	$213.13 - $281.01 $6.39 Million - $8.43 Million	30,000 New	30,000 $6.89 Million

309

24.2M

51K

54.8K

Ticker ICUI
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 23,899,400
Market Cap $4.03B
Description
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and Swa...

Get notified when there are updates to the investment portfolio of Homestead Advisers Corp, based on Form 13F filings with the SEC.

Stay updated on Homestead Advisers Corp with notifications on news.